I always say that I have the best job: I get to talk to smart people doing really interesting work. I have met dozens of entrepreneurs this year. There is amazing work going on around the country with payment reform, price transparency, nanorobots, incredibly early detection of cancer and sensors that can measure any biometric […]
Celexa. Zoloft. Prozac. Lexapro. Cymbalta. The list of FDA-approved drugs to treat depression and other neuropsychiatric disorders goes on and on. Finding the right one, or ones, for a patient is often a matter of guesswork, said James Burns, CEO of personalized medicine company Assurex Health (formerly AssureRx). “It’s usually ‘start low and go slow,’” […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Midwest VC firm Allos Ventures has $40 million in tow and is looking to use it to back a handful of emerging technology companies in the region. Allos’ recently closed second fund will follow the path of its first by targeting early-stage companies in high-growth sectors, namely software and technology-enabled business services, specialty healthcare providers, […]
Personalized medicine test maker AssureRx Health has raised a $12.5 million series C round of investment that it’ll use to help commercialize its tests that help doctors pick the right drugs based on a patient’s genes. The latest funding for the Cincinnati-area company is further evidence of how lucrative field investors believe personalized medicine can […]
Behavioral health personalized medicine company AssureRx Health has secured an $8 million line of credit as it looks to boost adoption of its genetic screening test for psychiatric drugs. Along with an $11 million series B round of funding that the company obtained last year, the line of credit will help fund the development of […]
Personalized medicine company AssureRx Health has released the next-generation version of its genetic screening test for psychiatric drugs. The Cincinnati-area company’s GeneSightRx test, which helps doctors pick the right psychiatric drugs for patients based on their genes, was launched in 2009. The test uses a cheek swab, mathematical algorithms and bioinformatics to narrow drug choices […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Personalized medicine test maker AssureRx Health has closed an $11 million Series B round of funding. The Cincinnati-area company will use the funding to expand sales and marketing for its GeneSightRx test, which helps doctors pick the right psychiatric drugs for patients based on their genes. The company launched the test in 2009. AssureRx will […]
AssureRx Health Inc. has added a sixth gene to its test that helps doctors pick the right psychiatric drugs for patients based on their genes.
AssureRx Health Inc., which sells a genetic test that helps doctors pick the right psychiatric drugs for patients based on their genes, has appointed a chief operating officer.
Riding the personalized medicine wave, AssureRx Health Inc. has found a lead investor for a Series A investment round that it hopes reaches $10 million.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Updated 12:13 p.m., July 9, 2010. AssureRx Health Inc., the pharmacogenetic test maker in Mason, Ohio, has closed the books on a $1.6 million round of largely angel investment completed last year. AssureRx is pioneering a diagnostics market within the emerging practice of personalized medicine. The Cincinnati-area, company has developed a genetic testing system that […]
“The age of personalized medicine is upon us,” said Jim Burns, chief executive of AssureRx Health Inc., the Cincinnati-area, company that has developed a genetic testing system to help doctors pick the right psychiatric drugs for patients. And in no other field is the need for personalized medicine so great. One in four of us […]
Personalized drug company AssureRx Health Inc. has promoted Donald Wright Jr. to senior vice president of operations and technology. Wright’s responsibilities will include managing the company’s Web-based software product development and overseeing information technology and molecular genetics laboratory operations, according to a statement from AssureRx. Wright has 20 years of experience in operations and product […]
Personalized drug company AssureRx Health Inc. has added a fifth gene to a genetic test and analysis that determines how psychiatric medicines could impact individual patients. AssureRx added gene CYP1A2 to its pharmacogenetic test, called GeneSightRx, which measures and analyzes more than 40 clinically important genetic variants that affect patients’ response to medications prescribed in […]
Queen City Angels invested in seven life sciences companies and one health information technology company last year, according to its 2009 annual operating report (pdf). The group of accredited investors finished the year with 12 investments, which included three IT companies and one company specializing in advanced materials. In addition, the angel group created a […]